Clinical Trials Directory

Trials / Unknown

UnknownNCT00299910

Inflammatory Response to Anti Inflammatory Therapy in Children With Sleep Disordered Breathing

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Soroka University Medical Center · Academic / Other
Sex
All
Age
2 Years – 10 Years
Healthy volunteers

Summary

This study will assess in a double blind placebo controlled fashion the effects of a 12 week course of oral montelukast/placebo on polysomnographic and radiological findings and will characterize the systemic (serum,urine) and local (upper airway collected biological samples) inflammatory response in children (2-10 years of age) with sleep disordered breathing, fittingthe inclusion and exclusion criteria.

Conditions

Interventions

TypeNameDescription
DRUGMontelukast

Timeline

Start date
2005-03-01
First posted
2006-03-07
Last updated
2008-05-21

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00299910. Inclusion in this directory is not an endorsement.